Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PLYX

Polaryx Therapeutics Inc

May 01 • 04:00PM ET

4.88

-0.37 -7.05 %

Healthcare • Biotechnology • USA • Micro • NASD

Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.19	Insider Own	91.81%	Shs Outstand	47.34M	Perf Week	0.62%
Market Cap	231.02M	Forward P/E	-	EPS next Y	-0.28	Insider Trans	0.01%	Shs Float	3.88M	Perf Month	-35.79%
Enterprise Value	225.88M	PEG	-	EPS next Q	-0.02	Inst Own	-	Short Float	6.13%	Perf Quarter	-
Income	-8.98M	P/S	-	EPS this Y	40.00%	Inst Trans	55.80%	Short Ratio	0.13	Perf Half Y	-
Sales	0.00M	P/B	50.61	EPS next Y	-133.33%	ROA	-165.04%	Short Interest	0.24M	Perf YTD	-86.06%
Book/sh	0.10	P/C	44.95	EPS next 5Y	-	ROE	-193.70%	52W High	48.91 -90.02%	Perf Year	-
Cash/sh	0.11	P/FCF	-	EPS past 3/5Y	-54.22% -	ROIC	-196.82%	52W Low	2.20 121.72%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.25% 12.25%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	70.40%	Oper. Margin	-	ATR (14)	0.88	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.55	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	36.99	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.55	EPS Q/Q	-106.54%	SMA20	-13.15%	Beta	-	Target Price	10.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-5.69%	Rel Volume	0.05	Prev Close	5.25
Employees	11	LT Debt/Eq	0.00	Earnings	Feb 25	SMA200	-21.57%	Avg Volume	1.82M	Price	4.88
IPO	Feb 02, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	82,101	Change	-7.05%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)